• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7,325
3,590
3,477
2,883
2,816

COUNTRY

2,410
900
279
269
228

CATEGORIES

  • 936
  • 179
    • 42
    • 213
    • 50
  • 182
  • 295
    • 51
  • 508
  • 227
  • 242
  • 60
  • 64
  • 868
  • 1,525
  • 823
  • 20
  • 501
  • 1,433
  • 2,413
    • 85
    • 124
    • 66
    • 65
    • 37
    • 37
    • 12
    • 12
    • 11
    • 18
  • 23
  • 270
  • 32
  • 2,637
SHOW ALL…

PRICE

2,843
7,931
17,087
30,328

PUBLISHED

2,226
3,785
12,616
30,328

PRODUCT TYPE

27,351
1,090
1,037
524
163
58
23
21
20
16
6
3
1

Pharmaceuticals

(30,328 Products)

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Pyelonephritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Pyelonephritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Pyelonephritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Pyelonephritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Pyelonephritis....

February 2015
FROM
Malaria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Malaria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Malaria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Malaria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Malaria. A key objective...

February 2015
FROM
Chronic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Chronic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Chronic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Chronic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Chronic Pain....

February 2015
FROM
Essential Thrombocythemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Essential Thrombocythemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Essential Thrombocythemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Essential Thrombocythemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

February 2015
FROM
Bone Metastasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Bone Metastasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Bone Metastasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Bone Metastasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Bone Metastasis....

February 2015
FROM
Atherosclerosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Atherosclerosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Atherosclerosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Atherosclerosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Atherosclerosis....

February 2015
FROM
HIV / AIDS-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 HIV / AIDS-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

HIV / AIDS-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“HIV / AIDS-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the HIV / AIDS. A...

February 2015
FROM
Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs...

February 2015
FROM
Xerosis (Dry Skin)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Xerosis (Dry Skin)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Xerosis (Dry Skin)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Xerosis (Dry Skin)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Xerosis...

February 2015
FROM
Diabetic Neuropathic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Diabetic Neuropathic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Diabetic Neuropathic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Diabetic Neuropathic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

February 2015
FROM
Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

February 2015
FROM
Absence Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Absence Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Absence Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Absence Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Absence Seizure....

February 2015
FROM
Global Serum Industry Report 2015 Global Serum Industry Report 2015 - Product Thumbnail Image

Global Serum Industry Report 2015

The Global Serum Industry Report 2015 is a professional and in-depth study on the current state of the serum industry. The report provides a basic overview of the industry including definitions,...

February 2015
FROM
Posterior Uveitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Posterior Uveitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Posterior Uveitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Posterior Uveitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Posterior...

February 2015
FROM
Pneumocystis Infection-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Pneumocystis Infection-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Pneumocystis Infection-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Pneumocystis Infection-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Pneumocystis...

February 2015
FROM
Deep Vein Thrombosis (DVT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Deep Vein Thrombosis (DVT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Deep Vein Thrombosis (DVT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Deep Vein Thrombosis (DVT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

February 2015
FROM
Cysticercosis (Taeniasis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Cysticercosis (Taeniasis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Cysticercosis (Taeniasis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Cysticercosis (Taeniasis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

February 2015
FROM
Neuroblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Neuroblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Neuroblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Neuroblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Neuroblastoma....

February 2015
FROM
Mycoses-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Mycoses-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Mycoses-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Mycoses-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Mycoses. A key objective...

February 2015
FROM
Retinitis Pigmentosa (Retinitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Retinitis Pigmentosa (Retinitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Retinitis Pigmentosa (Retinitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Retinitis Pigmentosa (Retinitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

February 2015
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S